Background. Hospital-specific surgical site infection (SSI) performance following colon surgery and abdominal hysterectomies can impact hospitals' relative rankings around quality metrics used to determine financial penalties. Current SSI surveillance largely focuses on SSI detected at the operative hospital.
Preventing surgical site infections (SSIs) is a national priority because of the impact of SSIs on both patient safety and healthcare costs [1] . As a consequence, the Centers for Medicare and Medicaid Services (CMS) requires all acute-care hospitals to report SSIs following colon surgery (COLO) and abdominal hysterectomy procedures (HYST) in order to receive their full annual reimbursement updates as part of the CMS Inpatient Prospective Payment System [2] . The Centers for Medicare and Medicaid Services also uses SSI outcomes, along with other hospital-associated infection (HAI) and quality metrics, to determine hospital reimbursement levels as part of both the Value-Based Purchasing and Hospital-Acquired Conditions programs based on hospitals' relative performance rankings. Centers for Medicare and Medicaid Services penalties for hospitals that fall into the lowest quartile of performance can translate into losses of millions of dollars for many healthcare facilities [3] .
Conventional SSI surveillance performed by hospital-based infection prevention programs uses information obtained from the health records of patients who have undergone surgery to identify those who have developed SSIs. Infection preventionists are required to apply standard Centers for Disease Control and Prevention (CDC) SSI surveillance criteria to determine a patient's SSI status; this involves review of a variety of health record information, including microbiology, radiology, readmission, and operative data. Because application of SSI surveillance criteria necessitates access to detailed health information, case detection is largely limited to SSI diagnosed at the hospital where the operation was performed (subsequently referred to as the operative hospital). Development of signs and symptoms and diagnosis of SSI, however, can be delayed by weeks and occasionally months from the time of surgery, and patients can seek postoperative care at other facilities (nonoperative hospitals). Although SSI outcomes submitted by hospitals to CMS should theoretically include cases detected at any healthcare facility, inclusion of SSIs detected at nonoperative hospitals depends on the completeness of nonstandardized, informal case-by-case communication of this information to infection preventionists at the operative hospital. Consequently, ascertainment of SSIs diagnosed and treated at nonoperative hospitals can be incomplete, and this surveillance deficit may produce inconsistent SSI capture across hospitals and lead to inaccurate assessments of performance.
Previously published work demonstrated the utility of diagnosis code-based screening algorithms to identify SSIs following COLO and HYST and found that diagnosis code-based screening identified 4 times as many COLO SSIs and twice as many HYST SSIs when compared with routine surveillance by hospital infection prevention programs [4] . These code-based algorithms have now been adopted by CMS and some states for surveys to validate the completeness of hospital SSI reporting [5, 6] .
In addition, our previous work also demonstrated that SSI surveillance methods that focus solely on SSIs detected at the operative hospital following total hip and knee arthroplasty procedures substantially underestimate SSI rates for some hospitals and can lead to inaccurate hospital, state, and national comparisons [7] .
In this study, we aimed to assess whether similar under-reporting is occurring for SSI surveillance following COLO and HYST. Because these surgical procedures are currently targeted by CMS to identify hospitals with relatively poor performance, hospitals' relative rankings on these SSI metrics have potential CMS reimbursement impact. The goal of this study was to estimate the proportion of COLO and HYST SSIs that would be missed by limiting surveillance to SSIs detected during the initial surgery admission and readmissions to the operative hospital. We applied the previously validated claims-based algorithm to a comprehensive state-wide administrative dataset.
PATIENTS AND METHODS
This was a retrospective cohort study using mandatory hospitalization data submitted to the California Office of Statewide Health Planning and Development (OSHPD) from all acute care hospitals in California. California hospitals are required to report person-level data on all inpatient admissions, including patient demographics and International Classification of Disease, Ninth (now Tenth) Revision, Clinical Modification (ICD-9-CM) diagnosis and procedure codes, using an unique encrypted patient identifier that is consistent for each individual over time and among admitting healthcare facilities [8] . For this study, we included all patients aged ≥18 years who received an ICD-9-CM procedure code for COLO or HYST based on CDC National Healthcare Safety Network (NHSN) operative procedure code mappings [9] between 1 March 2011 and 30 November 2013.
To minimize uncertainty of SSI estimates associated with small sample sizes, we excluded data from hospitals that performed <20 COLO or HYST during the study time period. Additional descriptive information was obtained for each patient from OSHPD data, including age, sex, ICD-9-CM diagnosis codebased comorbidities, and insurer. This study was approved at the institutional review boards of Harvard Pilgrim Health Care, the University of California Regents, and the California Committee for the Protection of Human Subjects.
Among patients meeting our study criteria, we identified SSIs based upon the presence of at least 1 previously validated ICD-9-CM diagnosis code suggestive of SSI (Table 1) within the NHSN 30-day postsurgery surveillance period [9] . To avoid uncertainty about SSI attribution, we excluded patients who underwent other common surgical procedures within the 60 days before surgery, including coronary artery bypass graft and colorectal, vascular, and hip and knee arthroplasty procedures. For patients undergoing other surgical procedures within the 30 days following COLO or HYST, surveillance for SSI codes was truncated at the time of the subsequent procedure. If 2 study procedures occurred during the same hospitalization, only the second procedure was included in the analysis. To avoid incorrectly interpreting diagnosis codes used to describe preexisting infections or conditions as evidence of a new SSI, patients who underwent COLO and who had an ICD-9-CM diagnosis code suggestive of infection (Table 1) classified as present on admission (POA) associated with the surgery hospitalization were excluded from the analysis. We used date of discharge when SSI codes were assigned during the index surgery hospitalization or date of readmission when SSI codes were assigned during readmissions as an estimate for the date of SSI detection.
Data Analysis
Clinical and demographic features of patients with and without SSI were compared using Fisher's exact test or the Wilcoxon rank sum test for nonparametric data. Time to readmission for SSI was compared for readmissions to the operative hospital versus readmissions for SSI to other hospitals using the Wilcoxon rank sum test. The percentages of hospital-specific SSIs identified during the index surgery hospitalization, SSI-related readmissions to the same hospital, and SSI-related readmissions to other hospitals were calculated. Hospitals with at least 1 SSI were grouped into 4 categories based on the percentage of SSIs detected at nonoperative hospitals: 0%, 1%-49%, 50%-99%, and 100%. Characteristics of hospitals within these groups were compared using 1-way analysis of variance or the Kruskal-Wallis test. All tests were 2-tailed with statistical significance set at P = .05.
Finally, we ranked hospitals by SSI rates using 2 SSI measures: (1) SSI detected at the operative hospital and (2) SSI detected at any California hospital. We produced a risk-adjusted ranking of hospitals using a generalized linear mixed model with hospital random effects developed by our group [10] . We risk-adjusted for individuals' ages in 10-year increments, sex, race, ethnicity, payer, and the presence of 30 ICD-9-CM-based comorbidity measures as described by Elixhauser [11] . Hospitals were ranked based on their empirical Bayes estimators or predicted random effects. This results in hospitals with low procedure volumes being drawn away from the extremes. Rankings were used to classify hospitals into quartiles based on SSI rates using only operative hospital data versus all hospital data. Statistical testing Table 2 . Among COLO patients, 52% were female, and the mean age at the time of surgery admission was 63.4 years. Among HYST patients, the mean age was 49.5 years. Medicare was noted as the payer for 50% and 13% of COLO and HYST admissions, respectively, whereas Medi-Cal (California Medicaid) represented 9% and 15% of payers. The mean length of stay for the index surgery hospitalization was 10.1 and 3.8 days for COLO and HYST, respectively. Patients who developed SSIs differed significantly from those who did not develop SSIs by index surgery hospitalization length of stay, insurer type, and presence of medical comorbidities, including diabetes mellitus, renal failure, obesity, and congestive heart failure ( Table 2) .
Five thousand nine hundred twenty-one (10.9%) COLO and 1481 (2.3%) HYST were assigned an ICD-9-CM diagnosis code for SSI within the 30 days following surgery. Forty-one percent of COLO and 52% of HYST SSIs occurred within the 10 days following surgery, and 82% of COLO and 85% of HYST SSIs occurred within 20 days. Although NHSN SSI methods truncate SSI surveillance for these procedures at 30 days following the procedure, when we extended surveillance for SSI codes over a 1-year postprocedure time period, we observed a tapering of new SSI codes out to 60 days, followed by a continued stable, very low rate of accrual of additional patients with SSI codes (Figure 1 ).
Among COLO with SSI codes, 66.1% (n = 3915) were first assigned during the index surgery hospitalization, 26.7% (n = 1580) during a readmission to the operative hospital, and 7.2% (n = 426) during a readmission to a facility that was not the operative hospital. Among HYST with SSI codes, 31% (n = 459) were first assigned during the index surgery hospitalization, 55.6% (n = 824) during a readmission to the operative hospital, and 13.4% (n = 198) during a readmission to another hospital.
For COLO, SSI readmission to the operative hospital occurred at a median of 13 days after surgery (IQR, 9.5-19 d) and readmissions to nonoperative hospitals at a median of 12.5 days after surgery (IQR, 8-19 d) . For HYST, SSI readmissions to the operative hospital occurred at a median of 11 days (IQR, 8-17 d) and readmissions to nonoperative hospitals at a median of 13 days (IQR, 8-19 d) . Neither of these differences were statistically significant.
The proportion of SSIs detected at a nonoperative hospital varied widely among individual hospitals (0%-100%). Characteristics of healthcare facilities within groupings based on increasing percentages of SSI readmissions detected at nonoperative hospitals were compared (Table 3) . Facilities with higher proportions of SSIs detected at nonoperative hospitals performed fewer procedures per year than facilities where most SSIs were detected by the operative hospital. This resulted in a greater discrepancy between SSI rates based on operative hospital data alone versus more comprehensive all-hospital data among lower-volume hospitals.
Including SSIs detected during hospitalizations at any California hospital resulted in assignment to a better relative rank for 58.6% (median improvement of 14 positions) of hospitals performing COLO and 64.4% (median improvement of 14 positions) of hospitals performing HYST, and a poorer rank for 38.3% (median worsening of 18 positions) of COLO hospitals and 32.2% (median worsening of 23 positions) of HYST hospitals. Ten percent of hospitals with improvements in relative ranking based on all-hospital data improved by ≥36 positions for COLO and ≥35 positions for HYST. Similarly, among hospitals with worsened ranking, 10% of rankings worsening by ≥63 positions for COLO and ≥74 positions for HYST (Figure 2) . Surgical site infection rates based on comprehensive SSIs detected at operative and nonoperative hospitals caused 11 (3.9%) COLO and 13 (4.8%) HYST hospitals to no longer fall within the "worst" (highest SSI rate) quartile and 7 (2.5%) COLO and 12 (4.4%) HYST hospitals to move out of the "best" (lowest SSI rate) quartile (Table 4) . Improvements in relative Figure 1 . Distribution of the number of days between colon surgery and abdominal hysterectomy procedures and surgical site infection as determined by diagnosis and procedure codes during the 365 days following surgery. Abbreviation: SSI, surgical site infection.
ranking resulting in movement out of the worst SSI quartile were more frequent among hospitals that performed relatively larger numbers of these surgical procedures.
DISCUSSION
With the implementation of value-based purchasing, hospital-specific SSI performance following COLO and HYST has become a major component of the metrics used to determine CMS reimbursement levels, and hospitals ranking within the lowest quartile of performance can incur substantial financial penalties. Because of this, standardized use of SSI surveillance definitions and methods that objectively and completely ascertain SSI cases across all hospitals has become increasingly important. Inaccuracies in assessing relative hospital performance can have important financial ramifications, especially if the impact of those inaccuracies on reported SSI rates is greater for some types of hospitals. Our results suggest that limiting SSI surveillance to infections detected at the operative hospital causes varying degrees of SSI underestimation, leading to inaccurate relative ranking of some hospitals. In general, limiting surveillance to the hospital where the operative procedure was performed appears to disadvantage hospitals with larger surgical volumes for which SSI ascertainment may be more complete. This finding may reflect a higher likelihood that patients return to larger hospitals that serve as referral centers when infectious complications occur. In addition, incomplete ascertainment of Figure 2 . Difference in rank for each hospital using risk-adjusted surgical site infection (SSI) rates based on SSI codes from the operative hospital versus any California hospital following colon surgery (A) and abdominal hysterectomy (B). Abbreviation: SSI, surgical site infection. SSIs at hospitals performing relatively fewer surgical procedures may lessen the potential of these hospitals to use SSI surveillance data to drive improvements in perioperative practices; this is particularly problematic given studies that suggest an inverse relationship between surgical volume and postoperative complications [12] [13] [14] . There are several limitations to this study. First, the use of diagnosis codes to identify SSIs may have over-or underestimated SSI rates. Surgical site infections that were detected and treated solely in the ambulatory setting would have been missed. Nevertheless, serious SSIs following surgery typically require rehospitalization and would likely have been captured by inpatient diagnosis codes. In addition, prior studies have shown that these codes perform far better than routine hospital surveillance, with higher sensitivity for detecting SSIs following COLO and HYST [4, 15] . In addition, state and national validation studies using medical record review to verify SSI status have confirmed the ability of these codes to accurately rank hospitals based on SSI outcomes [10, 15] . Second, excluding patients with diagnosis codes for infection classified as POA during the initial colon surgery hospitalization may have excluded some patients who had a combination of both preexisting infections and postoperative infectious complications from our analyses. Nevertheless, this is consistent with the current national surveillance standards, which also exclude these procedures. Third, this study did not assess the completeness of hospitals' SSI data submission into NHSN. Finally, this study only included data from California hospitals and did not assess the generalizability of these findings to hospitals located in other states.
These results suggest that routine SSI surveillance methods that focus mainly on SSIs detected during hospitalizations at facilities where these surgical procedures take place may significantly and disproportionately impact the completeness of SSI data among some hospitals and lead to inaccurate hospital, state, and national comparisons that can, in turn, lead to unfair distribution of financial penalties. Using large administrative datasets and applying validated diagnosis codes for SSI detection allows tracking of healthcare encounters for specific patients across multiple healthcare facilities. Nearly every state requires hospitals to provide diagnosis and procedure codes associated with each hospitalization to state agencies. Using these datasets to track individuals as they receive care across healthcare facilities and to identify possible SSI events could improve the completeness of SSI ascertainment and enhance the accuracy of comparisons among hospitals. Using diagnosis and procedure code-based screening in conjunction with conventional hospital-based SSI surveillance may provide a more complete and accurate picture of hospital-specific SSI performance. 
